Comparison of TaqMan™ real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication

被引:19
作者
Klein, SA
Karsten, S
Rüster, B
Klebba, C
Pape, M
Ottmann, OG
Hoelzer, D
Roth, WK
机构
[1] Univ Frankfurt, Med Klin 3, D-60590 Frankfurt, Germany
[2] Univ Frankfurt, Med Klin 2, D-60590 Frankfurt, Germany
[3] Blutspendedienst Hessen Deutsch Roten Kreuzes, Inst Transfus Med & Immunhamatol, D-60528 Frankfurt, Germany
关键词
real-time PCR; HIV-1; quantitation; p24; ELISA; RT-PCR;
D O I
10.1016/S0166-0934(02)00230-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study, TaqMan(TM) PCR was used to assess viral replication of HIV-1 infected cells in vitro. This PCR technique was compared with p24 ELISA as a standard method to monitor HIV-1 replication in cell culture. Hut78 T-lymphoblastoid cells were infected with different titres of HIV-1(IIIb) (MOI 0.05-0.0005). The course of HIV-1 replication was monitored by determination of p24 concentrations by ELISA in cell culture supernatants and by quantitation of HIV-1. gag RNA by TaqMan(TM) RT-PCR. Additionally, the number of HIV-1 proviral copies was assessed by TaqMan TM PCR. Monitoring of HIV-1 replication by p24 ELISA and TaqMan(TM) RT-PCR revealed comparable kinetics of infection. Both methods provided similar data on the exponential increase and on plateauing of HIV-1 replication. Furthermore, both methods were equally sensitive. However, a 7 log linearity of TaqMan(TM) HIV-1 gag PCR was demonstrated without dilution of the specimen, in contrast to p24 ELISA, where because of its narrow range of detectable p24 concentrations, sample dilution was necessary. Although determination of the number of proviral copies by TaqMan(TM) PCR does not measure HIV-1 replication, the kinetics of proviral copy number following in vitro inoculation of cells with HIV-1 was nearly the same as the kinetics of HIV-1 RNA copy numbers. In conclusion, TaqMan(TM) real-time RT-PCR was demonstrated as a reliable and sensitive tool to quantify and monitor HIV-1 replication in cell culture. It is suggested, therefore, that this technique be an alternative method to monitor HIV-1 replication in vitro. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 15 条
[1]   Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro [J].
BayardMcNeeley, M ;
Doo, H ;
He, SH ;
Hafner, A ;
Johnson, WD ;
Ho, JL .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (05) :547-553
[2]   Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation [J].
Bisset, LR ;
Bosbach, S ;
Tomasik, Z ;
Lutz, H ;
Schüpbach, J ;
Böni, J .
JOURNAL OF VIROLOGICAL METHODS, 2001, 91 (02) :149-155
[3]   Human Jurkat lymphocytes clones differ in their capacity to support productive human immunodeficiency virus type 1 multiplication [J].
Cervantes-Acosta, G ;
Cohen, ÉA ;
Lemay, G .
JOURNAL OF VIROLOGICAL METHODS, 2001, 92 (02) :207-213
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR [J].
Damond, F ;
Descamps, D ;
Farfara, I ;
Telles, JN ;
Puyeo, S ;
Campa, P ;
Leprêtre, A ;
Matheron, S ;
Brun-Vezinet, F ;
Simon, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4264-4268
[6]   Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay [J].
Désiré, N ;
Dehée, A ;
Schneider, V ;
Jacomet, C ;
Goujon, C ;
Girard, PM ;
Rozenbaum, W ;
Nicolas, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1303-1310
[7]   TaqMan 5′-nuclease human immunodeficiency virus type IPCR assay with phage-packaged competitive internal control for high-throughput blood donor screening [J].
Drosten, C ;
Seifried, E ;
Roth, WK .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4302-4308
[8]   REPLICATION OF PATIENT ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN T-CELLS - A SPECTRUM OF RATES AND EFFICIENCIES OF ENTRY [J].
FERNANDEZLARSSON, R ;
SRIVASTAVA, KK ;
LU, S ;
ROBINSON, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2223-2226
[9]   Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro [J].
Klebba, C ;
Ottmann, OG ;
Scherr, M ;
Pape, M ;
Engels, JW ;
Grez, M ;
Hoelzer, D ;
Klein, SA .
GENE THERAPY, 2000, 7 (05) :408-416
[10]  
Klein SA, 2000, EUR CYTOKINE NETW, V11, P47